Gene · 839
Papers3,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum biomarker screening and metabolic profiling analysis of nonalcoholic fatty liver disease patients using untargeted metabolomics and machine learning techniques. | Front Mol Biosci | 2026 | 41737828 | PubTator, text mining | PubMed |
| Liposomal encapsulation of a synthetic bromophenol for antitumor efficacy and apoptotic activity in cancer cells. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41686199 | PubTator, text mining | PubMed |
| APP-C31 pathology as a target in neurodegenerative diseases. | J Biomed Sci | 2026 | 41639863 | PubTator, text mining | PubMed |
| Chlorinated bis-4-hydroxycoumarins suppress flavivirus replication by inhibiting dengue virus type 2 translation and replication. | Sci Rep | 2026 | 41545435 | PubTator, text mining | PubMed |
| Design, synthesis, and mechanistic evaluation of alepterolic acid derivatives incorporating indole and piperazine moieties as anticancer agents targeting breast cancer. | Mol Divers | 2026 | 41353698 | PubTator, text mining | PubMed |
| The Intricate Role of Caspase-6 and Death Receptor-6 in Neurodegenerative Diseases. | Cell Biochem Biophys | 2026 | 41335291 | PubTator, text mining | PubMed |
| NiCo₂O₄ nanoparticles as chemosensitizers: enhancing doxorubicin-ınduced ıntrinsic apoptosis in A549 and MCF-7 cells. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41222690 | PubTator, text mining | PubMed |
| Nickel Ferrite Nanoparticles Potentiate the Anticancer Effects of Doxorubicin in Human Lung A549 Cancer Cells. | J Appl Toxicol | 2026 | 41069024 | PubTator, text mining | PubMed |
| Integrated application of target-based and ligand-based drug-designing approaches for the identification of novel caspase-6 inhibitors. | J Biomol Struct Dyn | 2026 | 39671711 | PubTator, text mining | PubMed |
| Caspase 6 deficiency exacerbates inflammatory bowel disease via enterocyte necroptosis and bacterial translocation. | Cell Death Discov | 2025 | 41390757 | PubTator, text mining | PubMed |
| Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with PARP and ATR inhibitors combination. | Nat Commun | 2025 | 41310329 | PubTator, text mining | PubMed |
| An NMR sample preparation case study: Considerations for the self-destructive protease caspase-6. | PLoS One | 2025 | 41270077 | PubTator, text mining | PubMed |
| Caspase-6 Is a Non-Apoptotic Effector of Shear-Induced Morphological Adaptation in Pulmonary Artery Endothelial Cells In Vitro. | Cells | 2025 | 41227316 | PubTator, text mining | PubMed |
| AIM2 drives inflammatory cell death and monkeypox pathogenesis. | Cell Mol Immunol | 2025 | 41225161 | PubTator, text mining | PubMed |
| Harnessing Fragment Merging and Chain Extension Approaches for Designing Phthalimidoalkyl-Arylidene Thiazolidinedione Hybrids: New Frontiers in Apoptosis-Inducing Cancer Treatment. | Arch Pharm (Weinheim) | 2025 | 41084127 | PubTator, text mining | PubMed |
| Polyphyllin I induces pyroptosis in diffuse large B-cell lymphoma by activating the caspase-6/ZBP1/NLRP3 signaling pathway. | Int Immunopharmacol | 2025 | 41027060 | PubTator, text mining | PubMed |
| New chalcone compound exhibits microrna-mediated anticancer properties in glioblastoma. | PLoS One | 2025 | 41004517 | PubTator, text mining | PubMed |
| Deciphering the Structural Biology of GFAP: Connotations of Its Potency in Presaging the Diagnosis for Traumatic Brain Injury and AD. | Neurol Int | 2025 | 41002922 | PubTator, text mining | PubMed |
| Enhancing Chemotherapeutic Efficacy in Lung Cancer Cells Through Synergistic Targeting of the PI3K/AKT Pathway with Small Molecule Inhibitors. | Int J Mol Sci | 2025 | 40943298 | PubTator, text mining | PubMed |
| Predictors of the Development of Newly Diagnosed Chronic Heart Failure in Patients with Shortness of Breath in Long-Term Post-COVID Syndrome. | Kardiologiia | 2025 | 40927934 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/papers?page=2